Comera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore Platform
Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today announced a significant expansion of its SQore patent portfolio with the issuance of four new patents and two new notices of allowance.
GlobeNewswireAug 8, 2023 08:00 ET
Short Interest in Comera Life Sciences Holdings, Inc. (NASDAQ:CMRAW) Drops By 46.0%
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRAW – Get Rating) was the target of a significant drop in short interest in the month of December. As of December 15th, there was short interest totallin
Defense WorldDec 30, 2022 05:11 ET
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRAW) Short Interest Update
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRAW – Get Rating) was the recipient of a large drop in short interest in November. As of November 30th, there was short interest totalling 15,000 shares,
Financial News LiveDec 17, 2022 12:01 ET
OTR Acquisition Corp. Reports Filed Confidential Submission Of S-4 Registration Statement Related To SPAC Deal With Comera Life Sciences
OTR Acquisition Corp. (NASDAQ:OTRAU, OTRA and OTRAW))), a publicly traded special purpose acquisition company (SPAC), today announced the confidential submission with the U.S. Securities and Exchange
Benzinga Real-time NewsFeb 4, 2022 08:06 ET
No Data
No Data